Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anaptysbio (ANAB) Other Non-Current Assets: 2016-2025

Historic Other Non-Current Assets for Anaptysbio (ANAB) over the last 9 years, with Sep 2025 value amounting to $256,000.

  • Anaptysbio's Other Non-Current Assets changed negligibly% to $256,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $256,000, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $256,000 for FY2024, which is negligibly% changed negligibly from last year.
  • Anaptysbio's Other Non-Current Assets amounted to $256,000 in Q3 2025, which was down 0.00% from $256,000 recorded in Q2 2025.
  • Anaptysbio's 5-year Other Non-Current Assets high stood at $477,000 for Q1 2021, and its period low was $256,000 during Q4 2021.
  • Its 3-year average for Other Non-Current Assets is $256,000, with a median of $256,000 in 2025.
  • Data for Anaptysbio's Other Non-Current Assets shows a maximum YoY crashed of 80.95% (in 2021) over the last 5 years.
  • Quarterly analysis of 5 years shows Anaptysbio's Other Non-Current Assets stood at $256,000 in 2021, then remained steady at $256,000 in 2022, then remained steady at $256,000 in 2023, then remained steady at $256,000 in 2024, then remained steady at $256,000 in 2025.
  • Its last three reported values are $256,000 in Q3 2025, $256,000 for Q2 2025, and $256,000 during Q1 2025.